BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Clover Therapeutics

Clover Therapeutics logo

United States of America based
$3.500 M

Clover Therapeutics is a young life science startup active in the field of nanobiotechnologies.

Clover's mission is to develop smart solutions for critical unmet medical needs, improving the efficacy of medical treatments and patients' quality of life.
We are now developing an innovative technology platform, based on drug delivery and biomimicry, whose first application will be the urological oncology.

aging research


AI Companies (Drug Discovery)   Aging Research  

R&D Platform



Preclinical  |  Visit website

Genetics R&D
We generate and analyze detailed clinico-genomic data to discover drug targets and select patients for treatment. Our clinical pipeline consists of two observational genetics studies which will genotype and sequence >5,000 AMD patients.

In the DIVERSITY study, whole genome sequences of AMD cases and controls of non-caucasians will be analyzed to discover novel genetic variants that affect AMD risk.

In the PROGRESSION study, the genotypes of patients with opposing genetic risk and disease progression are analyzed for novel genetic variants that modify disease progression.

Data obtained from studies will be used to inform novel drug target discovery and genetics-based patient selection for clinical development.




No services posted yet